There is not a day that goes by that I do not receive several emails from men who have prostate cancer.
There is no shame in getting prostate cancer.
But prostate cancer is the most poorly treated disease in modern medicine.
The treatment is almost always worse than the disease itself.
In today’s newsletter, I want to share some discoveries with you.
These are great discoveries that may help you prevent or fix prostate cancer.
In fact, aspirin curing prostate cancer could be the next big thing.
Let’s take a look at the first myth that is killing men.
This myth is that high testosterone causes prostate cancer.
Because of this insane myth, millions of men are being made into chemical eunuchs.
They are being castrated by drugs that suppress testosterone.
Their manhood is killed.
It’s all so tragic, and it’s unnecessary.
They consider this a cure for prostate cancer, but it’s all wrong!
The reality is that estrogen causes prostate cancer, not testosterone.
This study focuses on what is called high-grade prostate cancer.
High-grade prostate cancer is cancer that is said to require aggressive treatment from the moment it’s discovered.
And the results could not be clearer.
Estradiol (estrogen) was associated significantly with pathologic high grade prostate cancer, whereas testosterone failed to demonstrate any association.
What it means is that they found a clear connection between high estrogen levels and this aggressive cancer.
At the same time, they found no connection at all between this high-grade cancer and testosterone.
Testosterone is being blamed for another of estrogen’s crimes.
But will this stop millions of men from being prescribed chemicals that virtually make them women?
Of course not.
Big Pharma will have its day.
But fortunately, you’re here with me right now — so you can see the truth.
Now let’s look at a way to actually stop prostate cancer.
And it does it without dangerous drugs.
Remember, I am a health researcher, not a physician.
I don’t know you. I’m not treating you.
I’m not qualified to treat you.
Everything in this newsletter is information to help you make your own informed choices.
I’m providing you with eye-opening research to help you have more intelligent conversations with your doctor.
But we do want to arm you with the very best information we can find.
So, back to what we found that can stop prostate cancer without drugs!
It’s been shown that breast cancer and prostate cancer are very, very similar.
It is important to realize that because the study I’m going to show you is about breast cancer.
But since prostate cancer behaves in the same way, everything in this study applies just as strongly to prostate cancer.
The study reveals that aspirin can stop breast cancer.
And aspirin can even make cancer cells normal again.
I want to emphasize this strongly.
The SAME thing is going to happen with prostate cancer.
Since prostate cancer behaves exactly the same as breast cancer, that means aspirin will stop prostate cancer.
Prostate cancer will respond to aspirin in the same way as breast cancer cells do.
Aspirin not only prevents breast tumor cell growth, but also significantly reduces the self-renewal capacity and growth of breast tumor-initiating cells.
This is how aspirin stops cancer.
One of the hallmarks of cancer cells is what is called “cancer metabolism.”
Cancer metabolism happens when your cells undergo a chronic lack of oxygen.
The result is what is called oxidative stress.
Oxidative stress causes cells to start secreting estrogen to protect themselves.
But we know that high estrogen levels correlate with bad prostate cancer.
And one of the mechanisms of aspirin is to lower estrogen levels.
Aspirin can also fix oxidative stress and restore cells to normal.
Cells returning to normal means no more cancer!
Aspirin and cancer prevention should go hand in hand.
Now pay close attention here.
As women get to menopause, they produce far less estrogen.
In fact, men often have higher estrogen levels than their menopausal wives.
And it turns out that aspirin actually reduces estrogen.
This next study looked at the relationship between taking aspirin, and how often menopausal women get breast cancer.
Multiple studies have observed strong positive associations between levels of endogenous estrogens and breast cancer risk in postmenopausal women.
So, the study is telling us that using aspirin to reduce estrogen reduces the risk of breast cancer for menopausal women.
Exactly the same thing is true of men and prostate cancer.
You just saw one of those studies — the first one we looked at today.
Prostate cancer is associated with higher levels of estrogen.
Consuming reasonable amounts of aspirin meant that:
Mean estradiol levels were 10.5% lower among women who use it at least 15 days per month, compared to women with no such use.
The study actually showed that all nonsteroidal anti-inflammatory drugs lower estrogen levels.
This includes the aspirin we’re discussing, but also includes ibuprofen and acetaminophen.
However, only aspirin has been found to have all the other effects against cancer that we’ve been discussing.
Aspirin is the only one that has been found to reduce the oxidative stress and to return cells to normal.
So my money’s on taking aspirin for prostate cancer.
If I had prostate cancer here’s what I would do.
I would start taking aspirin in greater quantities.
And I’d monitor PSA (prostate-specific antigen) levels.
I would also take vitamin E because it also lowers estrogen.
I might even consider going on a prescribed aromatase inhibitor with my doctor’s prescription.
And we would monitor things.
I have very high hopes that with nutritional and supplement use lowering my estrogen, the prostate cancer would disappear.
Remember, with men who have prostate cancer, at least 25 to 30% of the time, the cancer disappears on its own.
It is quite possible that aspirin can speed up the end of cancer.
Now you know the truth.
Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition
Analgesic use and sex steroid hormone concentrations in postmenopausal women